Carol Pitzel Cruz Comments in Law360 on Enablement Analysis in Pharmaceutical Patent Litigation
Knobbe Martens partner Carol Pitzel Cruz was quoted in a recent Law360 article on the Federal Circuit’s decision in Wyeth v. AstraZeneca, a patent infringement dispute centered on Section 112...
What the USPTO’s New 30-Day Director Review Deadline for Decisions Instituting Trial Means for PTAB Petitioners and Patent Owners
Key Takeaway: In a precedential decision in Light & Wonder, Inc. v. Evolution Malta Ltd., U.S. Patent and Trademark Office Director Squires extended the deadline for requesting Director Review of...
Jarom Kesler Comments on USPTO Ex Parte Reexamination Denial Trends in Law360
In the Law360 article “USPTO Clamping Down Reexam Bids After IPR Denials,” Knobbe Martens partner Jarom Kesler shared how a recent ruling from the U.S. Patent and Trademark Office (USPTO)...